Am J Psychiatry 157:1606-1613, October 2000
© 2000 American Psychiatric Association
Disability and Quality of Life in Social Phobia: Epidemiologic Findings
Murray B. Stein, M.D., F.R.C.P.C., and
Yin M. Kean, M.P.H.
OBJECTIVE: Social phobia in clinical studies is vividly associated with extensive disability and reduced quality of life. It is difficult to obtain a clear portrayal of the impairment associated with social phobia in community samples. Furthermore, it has been unclear in prior studies to what extent indices were attributable to social phobia as opposed to comorbid major depression. The authors examined relevant data from the Ontario Health Survey Mental Health Supplement. METHOD: The Ontario Health Survey Mental Health Supplement, a survey of more than 8,000 residents of Ontario, Canada, aged 15–64, used the University of Michigan Composite International Diagnostic Interview to assign DSM-III-R diagnoses. Several indicators of disability and quality of life were included. The authors compared these indices for persons with and without social phobia and adjusted where indicated for the effects of major depression and relevant sociodemographic factors. RESULTS: Persons with social phobia were impaired on a broad spectrum of measures, ranging from dropping out of school to experiencing disability in one’s main activity. They were also significantly more likely than persons without social phobia to rate themselves as "low functioning" on the Quality of Well-Being Scale and to report dissatisfaction with many aspects of life. Depressive comorbidity seemed to contribute only modestly to these outcomes. CONCLUSIONS: Social phobia can be a serious, disabling anxiety disorder associated with marked reduction in quality of life. Impairment in social phobia is substantial, even in the absence of comorbid major depression.
This article has been cited by other articles:
|
|
|
|
 
J. Cairney, L. McCabe, S. Veldhuizen, L. M. Corna, D. Streiner, and N. Herrmann
Epidemiology of Social Phobia in Later Life
Am J Geriatr Psychiatry,
March 1, 2007;
15(3):
224 - 233.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. G Manfro
Lifetime prevalence of social anxiety disorder in the USA is 5%.
Evid. Based Ment. Health,
August 1, 2006;
9(3):
88 - 88.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. G. Hofmann, A. E. Meuret, J. A. J. Smits, N. M. Simon, M. H. Pollack, K. Eisenmenger, M. Shiekh, and M. W. Otto
Augmentation of exposure therapy with d-cycloserine for social anxiety disorder.
Arch Gen Psychiatry,
March 1, 2006;
63(3):
298 - 304.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. T. Penson, R. A. Partridge, M. A. Shah, D. Giansiracusa, B. A. Chabner, and T. J. Lynch Jr.
Fear of Death
Oncologist,
February 1, 2005;
10(2):
160 - 169.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Gelernter, G. P. Page, M. B. Stein, and S. W. Woods
Genome-Wide Linkage Scan for Loci Predisposing to Social Phobia: Evidence for a Chromosome 16 Risk Locus
Am J Psychiatry,
January 1, 2004;
161(1):
59 - 66.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. S. Tse and A. J. Bond
Reboxetine Promotes Social Bonding in Healthy Volunteers
J Psychopharmacol,
June 1, 2003;
17(2):
189 - 195.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. B. Stein, P. R. Goldin, J. Sareen, L. T. E. Zorrilla, and G. G. Brown
Increased Amygdala Activation to Angry and Contemptuous Faces in Generalized Social Phobia
Arch Gen Psychiatry,
November 1, 2002;
59(11):
1027 - 1034.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. M. Simon, M. W. Otto, N. B. Korbly, P. M. Peters, D. C. Nicolaou, and M. H. Pollack
Quality of Life in Social Anxiety Disorder Compared With Panic Disorder and the General Population
Psychiatr Serv,
June 1, 2002;
53(6):
714 - 718.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. K. Schneider and J. L. Levenson
Update in Psychiatry
Ann Intern Med,
February 19, 2002;
136(4):
293 - 301.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. B. Stein, J. Sareen, S. Hami, and J. Chao
Pindolol Potentiation of Paroxetine for Generalized Social Phobia: A Double-Blind, Placebo-Controlled, Crossover Study
Am J Psychiatry,
October 1, 2001;
158(10):
1725 - 1727.
[Abstract]
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2000
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
